|
Microchip Technology, Inc.
September 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Microchip Technology Inc. (“Microchip” or the “Company”) (NASDAQ: MCHP). Investors who purchased Microchip common stock between March 2, 2018 and August 9, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the District of Arizona against Microchip and certain executives on behalf of investors that acquired Microchip common stock during the Class Period.
|
|
Pretium Resources, Inc.
September 18, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Pretium Resources, Inc. (“Pretium” or the “Company”) (NYSE: PVG). Investors who purchased Pretium securities between July 21, 2016 and September 6, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Southern District of New York against Pretium and certain executives on behalf of investors that acquired Pretium securities during the Class Period.
|
|
Qurate Retail, Inc.
September 18, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Qurate Retail, Inc. (“Qurate” or the “Company”) (NASDAQ: QRTEA). Investors who purchased Qurate securities between August 5, 2015 and September 7, 2016 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the District of Colorado against Qurate and certain executives on behalf of investors that acquired Qurate securities during the Class Period.
|
|
AbbVie, Inc.
September 18, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of AbbVie Inc. (“AbbVie” or the “Company”).
|
|
OPKO Health, Inc.
September 11, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of OPKO Health, Inc. (“OPKO” or the “Company”) (Nasdaq: OPK).
|
|
USA Technologies, Inc.
September 11, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of USA Technologies, Inc. (“USA Technologies” or the “Company”), which is based in Malverne, Pennsylvania (Nasdaq: USAT).
|
|
Danske Bank A/S
September 11, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of Danske Bank A/S American Depository Shares (“Danske” or the “Company”) (OTC: DNKEY) (CUSIP: 236363206).
|
|
CV Sciences, Inc.
September 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of CV Sciences, Inc. (“CV Sciences” or the “Company”) (OTC: CVSI). Investors who purchased CV Sciences common stock between June 19, 2017 and August 20, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the District of Nevada against CV Sciences and certain executives on behalf of investors that acquired CV Sciences common stock during the Class Period.
|
|
CBS Corporation
September 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of CBS Corporation (“CBS” or the “Company”) (NYSE: CBS). Investors who purchased CBS securities between February 14, 2014 and July 27, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Southern District of New York against CBS and certain executives on behalf of investors that acquired CBS securities during the Class Period.
|
|
Nevro Corporation
September 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Nevro Corporation (“Nevro” or the “Company”) (NYSE: NVRO). Investors who purchased Nevro common stock between January 8, 2018 and July 12, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Northern District of California against Nevro and certain executives on behalf of investors that acquired Nevro common stock during the Class Period.
|
|
Impinj, Inc.
August 22, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Impinj, Inc. (“Impinj” or the “Company”) (NASDAQ: PI). Investors who purchased Impinj securities between May 7, 2018 and August 2, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Central District of California against Impinj and certain executives on behalf of investors that acquired Impinj securities during the Class Period.
|
|
Sinclair Broadcast Group, Inc.
August 10, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Sinclair Broadcast Group, Inc. (“Sinclair” or the “Company”) (NASDAQ: SBGI). Investors who purchased Sinclair securities between February 22, 2017 and July 19, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the District of Maryland against Sinclair and certain executives of the Company on behalf of investors that purchased or otherwise acquired Sinclair common stock during the Class Period.
|
|
Tesla, Inc.
August 9, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Tesla, Inc. (“Tesla” or the “Company”) (NASDAQ: TSLA) concerning potential securities law violations. Investors who purchased Tesla securities may be affected.
|
|
Ampio Pharmaceuticals, Inc.
August 8, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Ampio Pharmaceuticals, Inc. (“Ampio” or the “Company”) (NYSE: AMPE) concerning potential securities law violations. Investors who purchased Ampio securities may be affected.
|
|
GDS Holdings Limited
August 1, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating GDS Holdings Limited (“GDS” or the “Company”) (NASDAQ: GDS) concerning potential securities law violations. Investors who purchased GDS American Depositary Shares, or “ADSs” that trade under the symbol GDS may be affected.
|
|
ACADIA Pharmaceuticals Inc.
August 1, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of ACADIA Pharmaceuticals Inc. (“ACADIA” or the “Company”) (Nasdaq: ACAD). Investors who purchased ACADIA securities between April 29, 2016 and July 9, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court, Southern District of California against ACADIA and certain executives on behalf of investors that acquired ACADIA securities during the Class Period.
|
|
Farmland Partners Inc.
July 24, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Farmland Partners Inc. (“Farmland” or the “Company”) (NYSE: FPI). Investors who purchased Farmland securities between May 9, 2017 and July 10, 2018 (the “Class Period”) may be affected.
|
|
Prothena Corporation plc
July 24, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Prothena Corporation plc (“Prothena” or the “Company”) (NASDAQ: PRTA). Investors who purchased Prothena common stock between October 15, 2015 and April 20, 2018 (the “Class Period”) may be affected. A Class Action has been filed against Prothena and certain current and former Company executives on behalf of investors who purchased Prothena’s publicly traded common stock during the Class Period.
|
|
Glencore plc
July 9, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Glencore plc (“Glencore” or the “Company”) (OTC: GLNCY, GLCNF) concerning potential securities law violations. Investors who purchased Glencore securities may be affected.
|
|
Gogo, Inc.
July 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of Gogo Inc. (“Gogo” or the “Company”) (NASDAQ: GOGO). Investors who purchased or otherwise acquired Gogo securities between February 27, 2017 and May 7, 2018 (the “Class Period”) may be affected.
|
|
PolarityTE, Inc.
July 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of PolarityTE, Inc. (“PolarityTE” or the “Company”) (NASDAQ: COOL). Investors who purchased PolarityTE common shares between March 31, 2017 and June 22, 2018 (the “Class Period”) may be affected.
|
|
Sibanye Gold Limited
July 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of Sibanye Gold Limited (“Sibanye” or the “Company”) (NYSE: SBGL). Investors who purchased Sibanye securities, including American Depositary Receipts (“ADRs”), between April 7, 2017 and June 26, 2018 (the “Class Period”) may be affected. A Class Action has been filed on behalf of investors who purchased or otherwise acquired Sibanye’s publicly traded securities during the Class Period.
|
|
SITO Mobile Ltd.
June 18, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of SITO Mobile Ltd. (“SITO Mobile” or the “Company”) (NASDAQ: SITO).
|
|
Ormat Technologies, Inc.
June 13, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Ormat Technologies, Inc. (“Ormat” or the “Company”) (NYSE: ORA). Investors who purchased shares of Ormat securities between August 8, 2017 and May 15, 2018 (the “Class Period”) may be affected.
|
|
Aegean Marine Petroleum Network Inc.
June 7, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Aegean Marine Petroleum Network Inc. (“Aegean Marine” or the “Company”) (NYSE: ANW), a marine fuel logistics company. Investors who purchased shares of Aegean Marine securities between April 28, 2016 and June 4, 2018 (the “Class Period”) may be affected.
|
|
Fluor Corporation
June 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Fluor Corporation (“Fluor” or the “Company”) (NYSE: FLR). Investors who purchased shares of Fluor common stock may be affected.
|
|
ADT, Inc.
June 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of ADT Inc. (“ADT” or the “Company”) (NYSE: ADT). ADT provides security systems and services.
|
|
PPG Industries, Inc.
June 5, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of PPG Industries, Inc. (“PPG” or the “Company”) (NYSE: PPG). PPG purports to manufacture and distribute a broad range of paints, coatings and specialty materials in the United States and internationally.
|
|
Kulicke and Soffa Industries, Inc.
May 29, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Kulicke and Soffa Industries, Inc. (“Kulicke and Soffa” or the “Company”) (NASDAQ: KLIC), a company that designs, manufactures, and sells capital equipment and expendable tools to assemble semiconductor devices.
|
|
Rockwell Medical
May 24, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Rockwell Medical, Inc. (“Rockwell Medical” or the “Company”) (NASDAQ: RMTI), a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease.
|
